Avacta Group Plc
AVCT.L
Price:
$64.7028
Market Cap:
$231.87M
Avacta Group Plc, a clinical stage biopharmaceutical company, develops cancer therapies and diagnostics based on its proprietary Affimer and pre|CISION platforms in the United Kingdom, North America, South Korea, and rest of Asia and Europe. It operates through Diagnostics and Therapeutics segments. The company develops custom Affimer proteins for customer products and in-house diagnostic assays. It also develops AffiDX SARS-CoV-2 lateral flow rapid antigen tests, as well as Affimer reagents for third party products; and novel cancer immunotherapies combining proprietary platforms. The company has a research collaboration with pre|CISION technology incorporates a substrate that is sensitive ...[Read more]
Industry
Biotechnology
IPO Date
2003-09-08
Stock Exchange
LSE
Ticker
AVCT.L
The ROE as of September 2024 (TTM) for Avacta Group Plc (AVCT.L) is -112.01%
According to Avacta Group Plc’s latest financial reports and current stock price. The company's current ROE is -112.01%. This represents a change of 47.96% compared to the average of -75.70% of the last 4 quarters.
Avacta Group Plc (AVCT.L) Historical ROE (quarterly & annually)
How has AVCT.L ROE performed in the past?
The mean historical ROE of Avacta Group Plc over the last ten years is -59.93%. The current -112.01% ROE has changed 86.89% with respect to the historical average. Over the past ten years (40 quarters), AVCT.L's ROE was at its highest in in the March 2009 quarter at 0%. The ROE was at its lowest in in the December 2022 quarter at -165.73%.
Average
-59.93%
Median
-41.97%
Minimum
-214.22%
Maximum
-5.17%
Avacta Group Plc (AVCT.L) ROE by Quarter and Year
Discovering the peaks and valleys of Avacta Group Plc ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 924.27%
Maximum Annual ROE = -5.17%
Minimum Annual Increase = -75.54%
Minimum Annual ROE = -214.22%
| Year | ROE | Change |
|---|---|---|
| 2023 | -114.41% | -46.59% |
| 2022 | -214.22% | 235.55% |
| 2021 | -63.84% | 109.28% |
| 2020 | -30.50% | -28.57% |
| 2019 | -42.71% | 3.58% |
| 2018 | -41.23% | 93.56% |
| 2017 | -21.30% | 64.37% |
| 2016 | -12.96% | -75.54% |
| 2015 | -52.99% | 924.27% |
| 2014 | -5.17% | -47.10% |
Avacta Group Plc (AVCT.L) Average ROE
How has AVCT.L ROE performed in the past?
The current ROE of Avacta Group Plc (AVCT.L) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
-130.82%
5-year avg
-93.14%
10-year avg
-59.93%
Avacta Group Plc (AVCT.L) ROE vs. Peers
How is AVCT.L’s ROE compared to its peers?
Avacta Group Plc’s ROE is greater than Omega Diagnostics Group PLC (-35.47%), greater than Novacyt S.A. (-39.90%), greater than Synairgen plc (-58.75%), greater than genedrive plc (-281.82%), greater than Hemogenyx Pharmaceuticals Plc (-206.51%),
| Company | ROE | Market cap |
|---|---|---|
| -35.47% | $4.94M | |
| -39.90% | $50.14M | |
| -58.75% | $8.81M | |
| -281.82% | $11.32M | |
| -206.51% | $18.06M |
Build a custom stock screener for Avacta Group Plc (AVCT.L) and other stocks
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Avacta Group Plc using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
Avacta Group Plc (AVCT.L) and other stocks custom spreadsheet templates
The easiest way to analyze a company like Avacta Group Plc or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
Frequently asked questions❓
What is the ROE?
How can you use the ROE?
What is Avacta Group Plc's ROE?
How is the ROE calculated for Avacta Group Plc (AVCT.L)?
What is the highest ROE for Avacta Group Plc (AVCT.L)?
What is the 3-year average ROE for Avacta Group Plc (AVCT.L)?
What is the 5-year average ROE for Avacta Group Plc (AVCT.L)?
How does the current ROE for Avacta Group Plc (AVCT.L) compare to its historical average?